Immediate Effects of Dynamic Cupping on Median Nerve's Mechanosensitivity

Healthy Clinical Trial

Official title:

Immediate Effects of Dynamic Cupping on Median Nerve's Mechanosensitivity, Measured by the Upper Limb Neurodynamic Test 1 (ULNT1) in Healthy Participants: A Randomized Controlled Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04688892
• Other study ID #: FISIO-1-28102019
• Status: Completed
• Phase: N/A
• Start date: December 11, 2020
• Est. completion date: December 30, 2020

Study information

• Verified date: September 2021
• Source: University Fernando Pessoa
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose oh this study is to verify the immediate effects of dynamic cupping on median nerve's mechanosensitivity, measured by the upper limb neurodynamic test 1 (ULNT1) in healthy participants.

Description:

After completing the socio-demographic and clinical questionnaire, the participants will be randomly assigned into two designated groups, the Intervention Group (IG; n = 30) (dynamic cupping therapy throughout the median nerve course) and the Control Group (CG; n = 30) (remained at rest for 5 minutes), using the software www.graphpad.com/quickcals.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: December 30, 2020
• Est. primary completion date: December 16, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Healthy university students of both genders with normal mobility of the joints of the upper quadrant of the body.

Exclusion Criteria:

• Deformities in the upper quadrant region of the body;

• Complaints in this region in the last 6 months;

• Surgical procedures or musculoskeletal, cardiac, renal, metabolic, neurological and or oncological pathologies of the upper quadrant that may disturb nerve function;

• Not present any mechanosensitive response to ULNT1;

• Pregnant women;

• Ingestion of non-steroidal anti-inflammatory drugs or consumption of any type of narcotic drugs and participants who have drunk alcohol in the last 12 hours.

Related Conditions & MeSH terms

• Healthy

Intervention

Device:
• Cupping
dynamic cupping

Locations

Country	Name	City	State
Portugal	Ricardo Cardoso	Porto

Sponsors (1)

Lead Sponsor	Collaborator
University Fernando Pessoa

Country where clinical trial is conducted

Portugal, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	change in elbow extension range of motion	Data will be collected in two moments: baseline (M0) and after the application of cupping for intervention group or after a resting period for control group (M1).; The M0 will consist in performing the ULNT1 on the dominant upper limb for each participant. The participants will remain in a supine position on a massage table with the body aligned, exposing the test forearm for the placement of the smartphone through an armband. The head and cervical spine will be stabilized at the maximum comfortable lateral inclination using a foam pillow. The ULNT1 sequence used was: (1) maximum contralateral cervical inclination; (2) arm at 90º of shoulder abduction preventing scapular elevation; (3) 90º of external rotation of the shoulder and elbow flexion at 90º (defined as the initial position or 0º of range of motion under test); (4) supination of the forearm; (5) wrist and fingers extension; and (6) elbow extension.	Baseline (M0), Immediately after intervention or control (M1).